F. No. DC-DT-15011(11)/122/2025 Government of India Directorate General of Health Services Central Drugs Standard Control Organisation (DTAB-DCC Division)

Order

FDA Bhwan,New Delhi-110002 Date: | SEP

Subject: Stickering on Medical Products due to reduction in Goods & Service Tax (GST) rate — regarding

With reference to the recent decision of the Government regarding rationalization of Goods & Services Tax (GST) rate structures wherein the GST rates of drugs and formulations have been reduced and will come into effect from 22.09.2025.

In this regard in exercise of the powers conferred under the Drugs and Cosmetics Act, 1940 and rules thereunder, the Central Licensing Authority (CLA) has no objection to affix sticker of the revised Maximum Retail Price (MRP) by the importers as well as manufacturers of class C and D medical devices for implementation of GST within 3 months from the date of this order

This is for the information of all the stakeholders concerned.

Yours faithfully,

Key Qo (Dr. Raj ngh |Raghuvanshi) Drugs Controller General (India)

To,

1. All the importers 2. Manufacturers of class C and D medical devices

Copy for information:

1. PPS to Secretary DoP 2. PPS to DGHS 3. PS to Chairman, NPPA 4. PS to JS (R), MoHFW, Nirman Bhawan, New Delhi 5. All Zonal/Sub Zonal offices of CDSCO 6. Associations — IDMA/IPA/OPPI/FICCI/FOPE/CII/AiMeD 7. Website of CDSCO

F. No. DC-DT-15011(11)/122/2025 Government of India

Directorate General of Health Services Central Drugs Standard Control Organisation (DTAB-DCC Division)

FDA Bhwan,New Delhi-110002 Date:

To,

All the States/UTs Drugs Controller

Subject: Stickering on Medical Products due to reduction in Goods & Service Tax (GST) rate — regarding

Sir/Madam,

This is with reference to the recent decision of the Government regarding rationalization of Goods & Services Tax (GST) rate structures wherein the GST rates of drugs and formulations have been reduced and will come into effect from 22.09.2025.

In this regard, you are requested to expedite the process of issuance of no objection for alteration of labei (stickering) by the manufacturers under relevant rules made under Drugs and Cosmetics Act, 1940 for implementation of GST.

Action taken in the matter may be communicated to this Directorate.

Yours faithfully,

olenon Raghuvanshi) Drugs Controller General (India)

\

Copy for information:

1. PPS to Secretary DoP

2. PPS to DGHS

3. PS to Chairman, NPPA 4. PS to JS (R), MoHFW, Nirman Bhawan, New Delhi

4. All Zonal/Sub Zonal offices of CDSCO

5. Associations — IDMA/IPA/OPPI/FICCI/FOPE/CII/AiMeD

6. Website of CDSCO